Company news
Microbix Biosystems Inc. news in 2008
Microbix Biosystems Inc.'s news releases, calls and decks from 2008, newest first.
Microbix Uses Core Business Cashflow To Fund Late-Stage Pipeline To Build Shareholder Value In 2009
December 10, 2008
Microbix Enters The Urokinase Market
September 24, 2008
Microbix Continues Progress in Implementing Strategic Plan in Q3
August 13, 2008
Microbix Enters into Joint Venture in China to Build and Operate One of the Largest Influenza Vaccine Manufacturing Facilities in the World
June 23, 2008
Microbix and ImaRx Agree to Terminate Letter of Intent
June 11, 2008
Microbix VIRUSMAX(TM) Technology Continues to Attract Interest from Vaccine Manufacturers
June 5, 2008
Reporters/Editors: ^China grants patent protection to Microbix for its influenza vaccine yield enhancement technology
May 27, 2008
Microbix Makes Significant Progress in Implementing Strategic Plan in Q2
May 14, 2008
Microbix to spin off Urokinase into newly formed Klarogen Biotherapeutics; Klarogen to acquire all remaining Urokinase inventory, sales and marketing infrastructure and NDA from ImaRx upon completion of financing
May 7, 2008
New Larger Manufacturing Plant Ensures Microbix Will Continue to Meet Growing Demand for its Virology Products
April 22, 2008
Microbix Announces First Quarter Results
February 13, 2008
ImaRx and Microbix sign Letter of Intent to manufacture and further develop the FDA-approved clot-dissolving drug, Abbokinase(R)
January 22, 2008